Novartis Ag NVS
NYSE NVS
$163.71 +1.16 (+0.71%)
At close: Nov 9, 2026 · 4:00 PM EST

Novartis Ag (NVS) EV to EBITDA (2009 - 2026)

Updated

Novartis Ag's EV to EBITDA came in at 13.78 for Q1 2026, up 26.7% from 10.87 a year earlier.

Analysis

Novartis Ag (NVS) EV to EBITDA (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Novartis Ag reported EV to EBITDA of 12.41, up 37.2% year-over-year; for FY2017, it was 10.97, up 7.6% from FY2016.

  • Going back by year, EV to EBITDA was 10.19 in FY2016 (-16.5%), 12.21 in FY2015 (+15.4%), 10.58 in FY2014 (+9.2%) and 9.68 in FY2013 (+39.7%).
  • The Q1 2026 figure represents the highest quarterly EV to EBITDA since Q2 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Vertex Pharmaceuticals 139.96 Bn 111.95 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 13.78
Mar 31, 2025 10.87
Mar 31, 2024 10.60
Mar 31, 2023 10.61
Mar 31, 2022 10.92
Mar 31, 2021 12.43
Mar 31, 2020 12.16
Mar 31, 2019 13.13
Mar 31, 2018 11.10
Dec 31, 2017 11.02
Sep 30, 2017 11.99
Jun 30, 2017 11.75
Mar 31, 2017 10.46
Dec 31, 2016 10.19
Sep 30, 2016 11.24
Jun 30, 2016 12.07
Mar 31, 2016 10.42
Dec 31, 2015 12.21
Sep 30, 2015 12.70
Jun 30, 2015 15.93
API Access

Novartis Ag EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=NVS&period=max&api_key=YOUR_API_KEY